Skip to main navigation Skip to search Skip to main content

Improved resection and outcome of colon-cancer liver metastasis with fluorescence-guided surgery using in situ GFP labeling with a telomerase-dependent adenovirus in an orthotopic mouse model

  • Shuya Yano
  • , Kiyoto Takehara
  • , Shinji Miwa
  • , Hiroyuki Kishimoto
  • , Yukihiko Hiroshima
  • , Takashi Murakami
  • , Yasuo Urata
  • , Shunsuke Kagawa
  • , Michael Bouvet
  • , Toshiyoshi Fujiwara
  • , Robert M. Hoffman

Research output: Contribution to journal › Article › peer-review

Abstract

Fluorescence-guided surgery (FGS) of cancer is an area of intense development. In the present report, we demonstrate that the telomerase-dependent green fluorescent protein (GFP)-containing adenovirus OBP-401 could label colon-cancer liver metastasis in situ in an orthotopic mouse model enabling successful FGS. OBP-401-GFP-labeled liver metastasis resulted in complete resection with FGS, in contrast, conventional bright-light surgery (BLS) did not result in complete resection of the metastasis. OBP-401-FGS reduced the recurrence rate and prolonged over-all survival compared with BLS. In conclusion, adenovirus OBP-401 is a powerful tool to label liver metastasis in situ with GFP which enables its complete resection, not possible with conventional BLS.

Original languageEnglish
Article numbere0148760
JournalPloS one
Volume11
Issue number2
DOIs
Publication statusPublished - 02-2016
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

All Science Journal Classification (ASJC) codes

  • General

Fingerprint

Dive into the research topics of 'Improved resection and outcome of colon-cancer liver metastasis with fluorescence-guided surgery using in situ GFP labeling with a telomerase-dependent adenovirus in an orthotopic mouse model'. Together they form a unique fingerprint.

Cite this